Jin, Kairui
Luo, Jurui
Yu, Xiaoli
Guo, Xiaomao
Funding for this research was provided by:
National Natural Science Foundation of China (8197110875)
Key Clinical Specialty Project of Shanghai
Article History
Received: 3 February 2024
Accepted: 9 May 2024
First Online: 27 May 2024
Declarations
:
: The study protocol was approved by the Institutional Review Board of Fudan University Shanghai Cancer Center (Number 1804183-4). Protocol version 1.0 was approved on April 26, 2018. All participants provided written informed consent prior to randomization and are free to withdraw at any time. There are no dissemination plans of this trial.
: Not applicable.
: The authors declare no competing interests.